Search

everythinglearnresearchcommunity

for

Search:↓

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.

The document concludes that proper diagnosis and a combination of medical, hair-care, and surgical treatments are important for managing alopecia in black women.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

PCOS is a common hormonal disorder in women, marked by symptoms like hair growth and menstrual issues, and requires personalized treatment.

Minoxidil and Finasteride are effective for male baldness; more research is needed for hair aging treatments.

Niosomes are promising for skin drug delivery, offering benefits like improved drug penetration and stability.

The document concludes that understanding hair and feather regeneration can help develop new regenerative medicine strategies.

Male pattern baldness is mostly inherited, involves many genes, and is linked to other traits like early puberty and strong bones.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Different women's hair and skin glands respond to hormones in varied ways, which can cause unwanted hair growth even with normal hormone levels, and more research is needed to treat this effectively.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

Endocrine therapies for cancer significantly increase the risk of hair loss.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

COVID-19 may cause hair loss due to infection stress or treatments.

Men's hair loss is caused by hormones and genes, and can be treated with medication and surgery, while graying is due to aging and has no prevention except dyeing.

Hair thinning and loss in a girl with a rare metabolic disorder was linked to her condition.

Incisional slit grafting for hair transplantation gives natural-looking results and has a high success rate.

Dermoscopy has greatly improved the diagnosis of skin lesions and our understanding of their morphology and biology.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

At least 87% of Indian men experience hair loss, with type II being most common and severity increasing with age.

Niacin derivatives may increase hair fullness in women with hair loss.

Men with balding at age 45 had higher IGF-1 and lower IGFBP-3, suggesting these factors might be important in male pattern baldness.

PRFM may help treat hair loss, especially in mild cases.

The first in-prison dermatology clinic in the U.S. faced challenges and found certain skin conditions common among inmates, with rare cases of serious skin cancer.

Endoxan often causes hair loss, which usually starts in the third week of treatment.

The review concluded that male pattern baldness is mostly seen negatively, affecting attractiveness and social appeal.

Platelet-rich plasma (PRP) may help with various hair loss types, but more research is needed to find the best use method.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.